Log In
BCIQ
Print this Print this
 

Dipeptidyl peptidase-4 (DPP-4) (CD26)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Dipeptidyl peptidase-4 (DPP-4) (CD26)

BCIQ
Print ChartPrint this
Marketed, 15 Approved, 4 Registration, 1 Phase III, 2 Phase II, 4 Phase I/II, 1 Phase I, 1 Phase I, 4 Phase I, 1 Preclinical, 2 Discovery, 3
Phase of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPhase IIIRegistrationApprovedMarketed
Cancer

-

-

-

1

-

-

-

-

-

Cardiovascular

-

-

1

-

-

-

-

-

-

Endocrine / Metabolic

3

2

4

-

4

2

1

4

15

Renal

-

-

1

-

-

-

-

-

-




 Products Targeting Dipeptidyl peptidase-4 (DPP-4) (CD26)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

12

$163,930.4M

$161,060.5M

$2,224.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today